IPOPLUS

87

+0.9 +1.05%

11 May 2026

NSE Listed · Healthcare

Nephro Care India Limited (NEPHROCARE)

Volume: 8,000Avg Vol 1W: 13,200Avg Vol 1M: 20,41852W Range:50.05183
₹87 1.05%
Market Cap₹115 Cr
Current Price₹87
Previous Close₹86.1
High / Low (52w)₹183 / ₹50.05
Volume8,000
Avg Vol (1W)13,200
Avg Vol (1M)20,418
Stock P/E57.53
Book Value₹34.48
Dividend Yield0%
ROE5.93%
ROA1.38%
Revenue (TTM)
Revenue Growth
Profit Margin3.71%
Total Debt₹0 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹0.61
P/B2.52
Debt / Equity0
50 DMA₹73.76
200 DMA₹116.8
Day change+1.05%
Price Chart
87 31.47% · 1Y
188523.5L
2025-06-17
2026-05-11

20-day avg volume: 16K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 72% YoY.
Cons
  • Stock trades at a high P/E of 58.
Quarterly Results
MetricMar 2026Dec 2025
Revenue₹27 Cr₹23 Cr
EBITDA₹1 Cr₹1 Cr
Net Profit₹1 Cr₹0 Cr
EPS0.610.26
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹48 Cr₹28 Cr₹17 Cr₹3 Cr₹2 Cr₹1 Cr
EBITDA₹5 Cr₹6 Cr₹3 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹4 Cr₹4 Cr₹2 Cr₹0 Cr₹0 Cr₹0 Cr
EPS2.383.82.37-0.03135.15-14.78
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹68 Cr₹21 Cr₹8 Cr₹5 Cr₹1 Cr₹1 Cr
Total Liabilities₹15 Cr₹6 Cr₹6 Cr₹4 Cr₹1 Cr₹1 Cr
Equity₹53 Cr₹15 Cr₹3 Cr₹0 Cr₹0 Cr₹0 Cr
Total Debt₹0 Cr₹0 Cr₹2 Cr₹2 Cr₹1 Cr₹0 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operating₹9 Cr₹3 Cr₹4 Cr₹1 Cr₹0 Cr
Investing₹-40 Cr₹-8 Cr₹-2 Cr₹-3 Cr₹0 Cr
Financing₹35 Cr₹6 Cr₹0 Cr₹2 Cr₹0 Cr
Free Cash Flow₹9 Cr₹3 Cr₹4 Cr₹1 Cr₹0 Cr
Shareholding
Promoter 61.71% Institutions 2.02% Public 36.27%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search